Toronto Dominion Bank
CHRS icon

Toronto Dominion Bank’s Coherus Oncology CHRS Stock Holding History

Toronto Dominion Bank’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-57,877
Closed -$924K – 1496
2021
Q4 		$924K Buy
+57,877
New +$1.01M ﹤0.01% 1065
2021
Q3 		– Sell
-53
Closed -$1K – 1389
2021
Q2 		$1K Sell
53
-7
-12% -$99 ﹤0.01% 1323
2021
Q1 		$1K Buy
+60
New +$1.02K ﹤0.01% 1407

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Toronto Dominion Bank's CHRS Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 57,877 shares — an estimated $924K sold.

Toronto Dominion Bank first reported a position in CHRS in Q1 2021 and held it in 3 quarters. The position peaked at $924K in Q4 2021. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 57,877 Coherus Oncology shares in Q1 2022, an estimated $924K.
  • Toronto Dominion Bank first reported a position in Coherus Oncology in Q1 2021 and held it in 3 quarters.
  • Toronto Dominion Bank's Coherus Oncology position peaked at $924K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.